Wright Bonilla Discusses Gene Patents
14 November 2010
BioCentury This Week
News
Foley Partner Jacqueline Wright Bonilla appeared in a video segment published to BioCentury This Week on November 14, 2010 titled "Myriad Pro-Con." Wright Bonilla clarifies the definition of gene patents and makes the case for a company’s right to commercialize research and development that could lead to a diagnostic in a drug. She also discusses the Assn. for Molecular Pathology, et al. v. USPTO, et al. (ACLU v. Myriad) "gene patenting" case.
Related Services
Practice Areas
Insights
Steering Wheels Become Increasingly Optional
25 June 2019
Dashboard Insights
Federal Circuit Agrees “Pharmaceutical Composition” May Be Toxic
25 June 2019
PharmaPatents
No surprise - 72% of CEOs agree that Cybersecurity is critical!
25 June 2019
Internet, IT & e-Discovery Blog
Rathburn Named to ‘2019 Women in the Law’ List
20 June 2019
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ
Foley's Government Contracts Annual Update
16 October 2019
Liviona, MI